Xencor stock catapulted Monday to a nearly four-year high, breaking out on positive results for its experimental kidney cancer treatment. The post Xencor Catapults, Breaking Out On 'Unprecedented,' 'Profound' Cancer Data appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real